Massivemarkets

SEC Form 4

Sionna Therapeutics, Inc. (SION) insider trading

In the 12 months to Oct 26, 2026, 7 SION insiders reported open-market sales of $165.9M across 37 filings; no open-market purchases were filed.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$165.9M
37 filings · 7 insiders
Open-market purchases
$0
0 filings
Pre-arranged sales (10b5-1)
28 of 37
$112.6M of $165.9M sold (68%)

Who traded SION, and when

  • Sale
  • Sale, pre-arranged (10b5-1)

SION daily close from Oct 27, 2025 to Oct 26, 2026, between $3.60 and $51.04, last $3.69. 37 sale and 0 purchase filings by 7 insiders, marked at their filing dates. Peter A. Thompson, Director: sold $55.7M across 10 filings, first filed Nov 26, 2025, last Jul 9, 2026. OrbiMed Capital GP VIII LLC, Director: sold $49.2M across 8 filings, first filed Nov 26, 2025, last Jul 9, 2026. Peter Kolchinsky, Director: sold $33.3M across 4 filings, first filed Oct 28, 2025, last Sep 21, 2026. Rajeev M. Shah, Director: sold $10.0M across 4 filings, first filed Oct 28, 2025, last Sep 21, 2026. James G. Coulter, 10% owner: sold $10.0M across 1 filing, first filed Jan 26, 2026, last Jan 26, 2026. ORBIMED ADVISORS LLC, Director: sold $6.5M across 7 filings, first filed Nov 26, 2025, last May 29, 2026. Jennifer Fitzpatrick, Chief Legal Officer: sold $1.2M across 3 filings, first filed Dec 9, 2025, last Jul 7, 2026.

Largest mark · tap a row for others

Peter A. Thompson · Director

Filing 1 of 2 within a week · $25,417,386 total

Sale $22,945,044

510,583 shares at $44.94 avg

Filed Apr 16, 2026 · traded Apr 14

Pre-arranged (10b5-1) · close on filing date $45.24

SION daily closelast $3.69

Peter A. Thompson · Director

$55.7M sold

OrbiMed Capital GP VIII LLC · Director

$49.2M sold

Peter Kolchinsky · Director

$33.3M sold

Rajeev M. Shah · Director

$10.0M sold

James G. Coulter · 10% owner

$10.0M sold

ORBIMED ADVISORS LLC · Director

$6.5M sold

Jennifer Fitzpatrick · Chief Legal Officer

$1.2M sold
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Open-market trades

37 filings in the last 12 months
Other insider activity (not market trades) · 11 records
  • Option exercises3 records
  • Grants and awards8 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Pre-arranged (10b5-1)
The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Counted once
When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.

Frequently asked questions

Has Sionna Therapeutics, Inc.'s CEO sold stock?

No. Michael Cloonan (CEO) made no open-market sales filed as CEO in the last 12 months.

How current is SION’s insider data?

These are SION Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

Build with AI

Track SION insider trades with your agent

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for SION every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.